| Announce Date | 11/14/2025 |
| EPS Normalized Actual | $-0.01 (Beat by $0.21) |
| EPS GAAP Actual | $-0.01 (Beat by $0.21) |
| Revenue Actual | $10.309B |
| Revenue Surprise | Beat by $10309M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.18 |
| EPS GAAP Estimate | $-0.18 |
| Revenue Estimate | $0.013B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2026 | 0.09 | 37.67 | 0.09 | 0.09 | 1 |
| Dec 2025 | -0.16 | -21.19 | -0.16 | -0.16 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.01 | 0.05 | 10.309B | -21.79% | 10295.25M |
| FQ2 2025 (Jun 2025) | -0.11 | -0.05 | 0.012659B | -107112.26% | -1.09M |
| FQ1 2025 (Mar 2025) | -284.319 | -284.209 | 12.135B | -15.87% | 12122M |
| FQ4 2024 (Dec 2024) | -0.17 | -0.11 | 0.01492B | 9.73% | 1.42M |
| FQ3 2024 (Sep 2024) | -121.01 | -120.93 | 12.555B | 2.09% | 12541.75M |
| FQ2 2024 (Jun 2024) | 89.8 | 88.45741 | 13.572B | 99.9% | 13545.59M |
| FQ1 2024 (Mar 2024) | -215.34 | -215.34 | 14.061B | 10.75% | 14061M |
| FQ4 2023 (Dec 2023) | 0.06 | 0.06 | 0.013469B | -3.13% | 13.47M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.18
Consensus Revenue Estimates
0.013B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | -0.01 | -- | -0.01 | -0.01 | 1 |
| FQ3 2026 (Sep 2026) | 0.09 | 111.11 | 0.09 | 0.09 | 1 |
| FQ2 2026 (Jun 2026) | 0.02 | 650 | 0.02 | 0.02 | 1 |
| FQ1 2026 (Mar 2026) | -0.18 | -157855 | -0.18 | -0.18 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.01B | -- | 0.01B | 0.01B | 1 |
| FQ3 2026 (Sep 2026) | 0.02B | -66409.68 | 0.02B | 0.02B | 1 |
| FQ2 2026 (Jun 2026) | 0.02B | 16.17 | 0.02B | 0.02B | 1 |
| FQ1 2026 (Mar 2026) | 0.01B | -93246.15 | 0.01B | 0.01B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.06 | -0.01 | 0.05 | -500% |
| FQ2 2025 (Jun 2025) | -0.06 | -0.11 | -0.05 | 45.45% |
| FQ1 2025 (Mar 2025) | -0.11 | -284.319 | -284.209 | 99.96% |
| FQ4 2024 (Dec 2024) | -0.06 | -0.17 | -0.11 | 64.71% |
| FQ3 2024 (Sep 2024) | -0.08 | -121.01 | -120.93 | 99.93% |
| FQ2 2024 (Jun 2024) | 1.34259 | 89.8 | 88.45741 | 98.5% |
| FQ1 2024 (Mar 2024) | -215.34 | -215.34 | 100% | |
| FQ4 2023 (Dec 2023) | 0.06 | 0.06 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.01B | $10.31B | $10295.25M | 99.87% |
| FQ2 2025 (Jun 2025) | $0.01B | $0.01B | $-1.09M | -8.62% |
| FQ1 2025 (Mar 2025) | $0.01B | $12.14B | $12122M | 99.89% |
| FQ4 2024 (Dec 2024) | $0.01B | $0.01B | $1.42M | 9.52% |
| FQ3 2024 (Sep 2024) | $0.01B | $12.56B | $12541.75M | 99.89% |
| FQ2 2024 (Jun 2024) | $0.03B | $13.57B | $13545.59M | 99.81% |
| FQ1 2024 (Mar 2024) | $0B | $14.06B | $14061M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.01B | $13.47M | 100% |